London & Capital Asset Management Ltd
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1767559
London, X0
Position in TMO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$408,551,244
+$18,535,952 QoQ
Shares Held
814,886
+2.7% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
3.81%
of 13F equity value
Holder Rank
#68
of 2,606 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026London & Capital Asset Management Ltd holds $408,551,244 across 1 Diagnostics & Research name. TMO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
814,886 | $408,551,244 |
All Filings in TMO
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $408,551,244 | 814,886 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $390,015,292 | 793,472 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $455,572,861 | 786,216 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $58,681,114 | 120,987 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $51,152,022 | 126,158 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $54,562,835 | 109,652 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $35,646,679 | 68,521 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $37,602,870 | 60,790 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $32,402,482 | 58,594 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $40,743,402 | 70,101 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $37,000,309 | 69,708 | Shares | Other | 2024-01-30 | |
| 2023-09-30 | $33,003,296 | 65,202 | Shares | Other | 2023-11-15 | |
| No filing history on record for this holder in this stock. | ||||||